tert-butyl 4-((3-(4-methoxyphenyl)-3-oxopropyl)(methyl)amino)piperidine-1-carboxylate

Catalog No.: 
ACJLMI365
CAS No.: 
-
Molecular Formula: 
C21H32N2O4
Molecular Weight: 
376.50
tert-butyl 4-((3-(4-methoxyphenyl)-3-oxopropyl)(methyl)amino)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$358.00InquiryInquiry
250mg95%$715.00InquiryInquiry
1g95%$1283.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 4-((3-(4-methoxyphenyl)-3-oxopropyl)(methyl)amino)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-((3-(4-methoxyphenyl)-3-oxopropyl)(methyl)amino)piperidine-1-carboxylate
Molecular FormulaC21H32N2O4
Molecular Weight376.50
SMILESCOC1=CC=C(C(=O)C[CH2:1][N:1](C)C2CCN(C(=O)OC(C)(C)C)CC2)C=C1
InChI KeyVJGUMNPYIIAIIF-UHFFFAOYSA-N

Synthetic Route by SureRoute

1. ACJLMI365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDRZ650 route compound structure diagram
    ACHDRZ650147539-41-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJLMI365 route product structure diagram
    ACJLMI365-
Inquiry

2. ACJLMI365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDRZ650 route compound structure diagram
    ACHDRZ650147539-41-1In Stock
  2. Plus
  3. ACZCSO261 route compound structure diagram
    ACZCSO26135999-20-3In Stock
  4. Then
  5. ACJLMI365 route product structure diagram
    ACJLMI365-
Inquiry

3. ACJLMI365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHDRZ650 route compound structure diagram
    ACHDRZ650147539-41-1In Stock
  4. Plus
  5. ACTQFN952 route compound structure diagram
    ACTQFN952100-06-1In Stock
  6. Then
  7. ACJLMI365 route product structure diagram
    ACJLMI365-
Inquiry

Comments (0)